← Eichor
Condition: Severe Hypoglycemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Severe Hypoglycemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes M
Phase 1/Phase 2 · 1 location(s) · Otsuka Pharmaceutical Factory, Inc. · NCT06575426
Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups
Phase N/A · 3 location(s) · Forschungsinstitut der Diabetes Akademie Mergentheim · NCT07212075
The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France
Phase N/A · 21 location(s) · Tandem Diabetes Care, Inc. · NCT07211126
Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
NA · 1 location(s) · Defymed · NCT05221359
Longitudinal Study of the GLUcagon REsponse to Hypoglycemia in Children and Adolescents With New-onset Type 1 DIAbetes
NA · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT06770621
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · 29 location(s) · Vertex Pharmaceuticals Incorporated · NCT04786262
A Safety, Tolerability, and Efficacy Study of E-islet 01 in Participants With Type 1 Diabetes
Phase 1/Phase 2 · 1 location(s) · EndoCell Therapeutics, Inc. · NCT07126873
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.